Synthesis and Antitumor Activity of Novel Pyrimidinyl Pyrazole Derivatives(3)Synthesis and Antitumor Activity of 3-Phenylpiperazinyl-1-trans-propenes

  • Naito Hiroyuki
    Medicinal Chemistry Research Laboratory, Daiichi Pharmaceutical Co. Ltd.
  • Ohsuki Satoru
    Medicinal Chemistry Research Laboratory, Daiichi Pharmaceutical Co. Ltd.
  • Atsumi Ryo
    Drug Metabolism & Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd.
  • Minami Megumi
    New Product Research Laboratories III, Daiichi Pharmaceutical Co. Ltd.
  • Mochizuki Mineko
    New Product Research Laboratories III, Daiichi Pharmaceutical Co. Ltd.
  • Hirotani Kenji
    Discovery Research Laboratory, Daiichi Pharmaceutical Co. Ltd.
  • Kumazawa Eiji
    New Product Research Laboratories III, Daiichi Pharmaceutical Co. Ltd.
  • Ejima Akio
    Medicinal Chemistry Research Laboratory, Daiichi Pharmaceutical Co. Ltd.

書誌事項

タイトル別名
  • Synthesis and Antitumor Activity of Novel Pyrimidinyl Pyrazole Derivatives. III. Synthesis and Antitumor Activity of 3-Phenylpiperazinyl-1-trans-propenes

この論文をさがす

抄録

A series of novel 3-[4-phenyl-1-piperazinyl]-1-[5-methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-1-trans-propenes and related compounds were synthesized and evaluated by their cytotoxic activity against several tumor cell lines in vitro and in vivo antitumor activity against some tumor models when administered both intraperitoneally and orally. Compounds with the 3-chloropyridin-2-yl group (9g) and the 3-fluoro-5-substituted phenylpiperazinyl group (29b, c, and e) showed significantly potent cytotoxicity by in vitro testing. Among them, the 3-cyano-5-fluorophenyl derivative (29b) exhibited potent antitumor activity against several tumor cells including human carcinoma without causing undesirable effects in mice.

収録刊行物

参考文献 (34)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ